Beta Bionics

Beta Bionics is a biotechnology company that develops an integrated bionic pancreas system called the iLet.

Business Model:

Revenue: $0

Employees: 11-50

Detailed Beta Bionics Information

Geographic Data

Beta Bionics headquarters map

Address:

City: Boston

State: Massachusetts

Zip:

Country: United States

Financial Info

Stage:

series c

Raised Last:

$57M

Raised Total:

$193M

Metrics

3,367,349Website Global Rank

4,387Website Monthly Traffic

Twitter Followers

Description

Beta Bionics is a biotechnology company that develops an integrated bionic pancreas system called the iLet. The iLet Bionic Pancreas System was granted breakthrough designation in all configurations (insulin-only, glucagon-only, and bihormonal), including use with Zealand Pharma’s dasiglucagon, a glucagon analog with a unique stability profile in a ready-to-use aqueous solution. It also offers a bionic pancreas device for glucose metabolism to the diabetes community. Beta Bionics was founded in 2015 and is based in Boston, Massachusetts, United States.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
1/2019 Series B 6 $63M Dexcom
ArrowMark Partners
Eventide
LifeSci Venture Partners
RTW Investments LLC
Zealand Pharma
ArrowMark Partners
Dexcom
Eventide
LifeSci Venture Partners
RTW Investments LLC
Zealand Pharma
7/2019 Series B 6 $63M ArrowMark Partners
Eventide
Farallon Capital Management
Perceptive Advisors
RTW Investments LLC
Soleus Capital
ArrowMark Partners
Eventide
Farallon Capital Management
Perceptive Advisors
RTW Investments LLC
Soleus Capital
12/2017 Venture Round $2.5M
6/2016 Equity Crowdfunding $1M
2/2022 Series C $0 Novo Nordisk
ArrowMark Partners
Eventide
Farallon Capital Management
LifeSci Venture Partners
Perceptive Advisors
Pura Vida Investments
RTW Investments LLC
Soleus Capital
Novo Nordisk
ArrowMark Partners
Eventide
Farallon Capital Management
LifeSci Venture Partners
Perceptive Advisors
Pura Vida Investments
RTW Investments LLC
Soleus Capital
12/2015 Series A 2 $5M Novo Nordisk
Eli Lilly
Eli Lilly
Novo Nordisk
10/2018 Grant 1 $2M National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Diabetes and Digestive and Kidney Diseases
2/2022 Series C 9 $57M ArrowMark Partners
Eventide
Farallon Capital Management
LifeSci Venture Partners
Novo Nordisk
Perceptive Advisors
Pura Vida Investments
RTW Investments LLC
Soleus Capital
ArrowMark Partners
Eventide
Farallon Capital Management
LifeSci Venture Partners
Novo Nordisk
Perceptive Advisors
Pura Vida Investments
RTW Investments LLC
Soleus Capital
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research